Literature DB >> 24816040

Increased atherosclerosis in mice with increased vascular biglycan content.

Joel C Thompson1, Tao Tang1, Patricia G Wilson1, Meghan H Yoder1, Lisa R Tannock2.   

Abstract

OBJECTIVE: The response to retention hypothesis of atherogenesis proposes that atherosclerosis is initiated via the retention of atherogenic lipoproteins by vascular proteoglycans. Co-localization studies suggest that of all the vascular proteoglycans, biglycan is the one most closely co-localized with LDL. The goal of this study was to determine if over-expression of biglycan in hyperlipidemic mice would increase atherosclerosis development.
METHODS: Transgenic mice were developed by expressing biglycan under control of the smooth muscle actin promoter, and were crossed to the LDL receptor deficient (C57BL/6 background) atherosclerotic mouse model. Biglycan transgenic and non-transgenic control mice were fed an atherogenic Western diet for 4-12 weeks.
RESULTS: LDL receptor deficient mice overexpressing biglycan under control of the smooth muscle alpha actin promoter had increased atherosclerosis development that correlated with vascular biglycan content.
CONCLUSION: Increased vascular biglycan content predisposes to increased lipid retention and increased atherosclerosis development. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Atherosclerosis; Biglycan; LDL retention; Mice

Mesh:

Substances:

Year:  2014        PMID: 24816040      PMCID: PMC4054690          DOI: 10.1016/j.atherosclerosis.2014.03.037

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  28 in total

1.  Increased renal production of transforming growth factor-beta1 in patients with type II diabetes.

Authors:  K Sharma; F N Ziyadeh; B Alzahabi; T A McGowan; S Kapoor; B R Kurnik; P B Kurnik; L S Weisberg
Journal:  Diabetes       Date:  1997-05       Impact factor: 9.461

Review 2.  Developmental basis of vascular smooth muscle diversity.

Authors:  Mark W Majesky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-03-22       Impact factor: 8.311

3.  Elevated plasma levels of transforming growth factor-beta 1 in NIDDM.

Authors:  A Pfeiffer; K Middelberg-Bisping; C Drewes; H Schatz
Journal:  Diabetes Care       Date:  1996-10       Impact factor: 19.112

Review 4.  The response-to-retention hypothesis of early atherogenesis.

Authors:  K J Williams; I Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

5.  Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration.

Authors:  Yutaka Nakashima; Hiroshi Fujii; Shinji Sumiyoshi; Thomas N Wight; Katsuo Sueishi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-02-15       Impact factor: 8.311

6.  Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins.

Authors:  U Olsson; G Bondjers; G Camejo
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

7.  Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.

Authors:  Mariam Rodríguez-Lee; Gunnel Ostergren-Lundén; Boel Wallin; Jonatan Moses; Göran Bondjers; Germán Camejo
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-10-20       Impact factor: 8.311

8.  Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins.

Authors:  K D O'Brien; K L Olin; C E Alpers; W Chiu; M Ferguson; K Hudkins; T N Wight; A Chait
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

9.  Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development.

Authors:  Fei Huang; Joel C Thompson; Patricia G Wilson; Hnin H Aung; John C Rutledge; Lisa R Tannock
Journal:  J Lipid Res       Date:  2007-11-21       Impact factor: 5.922

10.  Distribution of glycosaminoglycans in the intima of human aortas: changes in atherosclerosis and diabetes mellitus.

Authors:  F Wasty; M Z Alavi; S Moore
Journal:  Diabetologia       Date:  1993-04       Impact factor: 10.122

View more
  16 in total

1.  Serglycin protects against high fat diet-induced increase in serum LDL in mice.

Authors:  Astri J Meen; Christian A Drevon; Gunnar Pejler; Trond G Jenssen; Ole Kristoffer Olstad; Magnus Åbrink; Svein O Kolset
Journal:  Glycoconj J       Date:  2015-09-21       Impact factor: 2.916

Review 2.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

3.  Elevated circulating TGF-β is not the cause of increased atherosclerosis development in biglycan deficient mice.

Authors:  Joel C Thompson; Patricia G Wilson; Alex P Wyllie; Adrian K Wyllie; Lisa R Tannock
Journal:  Atherosclerosis       Date:  2017-11-10       Impact factor: 5.162

Review 4.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

Review 5.  Toll-like Receptors in the Vascular System: Sensing the Dangers Within.

Authors:  Styliani Goulopoulou; Cameron G McCarthy; R Clinton Webb
Journal:  Pharmacol Rev       Date:  2016-01       Impact factor: 25.468

Review 6.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

7.  Serum Amyloid A Is an Exchangeable Apolipoprotein.

Authors:  Patricia G Wilson; Joel C Thompson; Preetha Shridas; Patrick J McNamara; Maria C de Beer; Frederick C de Beer; Nancy R Webb; Lisa R Tannock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

8.  A brief elevation of serum amyloid A is sufficient to increase atherosclerosis.

Authors:  Joel C Thompson; Colton Jayne; Jennifer Thompson; Patricia G Wilson; Meghan H Yoder; Nancy Webb; Lisa R Tannock
Journal:  J Lipid Res       Date:  2014-11-26       Impact factor: 5.922

9.  Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection.

Authors:  Tao Tang; Joel C Thompson; Patricia G Wilson; Meghan H Yoder; Julia Müeller; Jens W Fischer; Kevin Jon Williams; Lisa R Tannock
Journal:  J Mol Cell Cardiol       Date:  2014-08-02       Impact factor: 5.000

Review 10.  The arterial microenvironment: the where and why of atherosclerosis.

Authors:  Arif Yurdagul; Alexandra C Finney; Matthew D Woolard; A Wayne Orr
Journal:  Biochem J       Date:  2016-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.